Table 2.
Melanoma Subtype | CaD (n = 82) |
Placebo (n = 94) |
||
---|---|---|---|---|
No. | % | No. | % | |
Total invasive melanomas | 44 | 54 | 58 | 62 |
Total in situ melanomas | 38 | 46 | 36 | 38 |
History of NMSC (total) | 10 | 24 | ||
Invasive | 5 | 50 | 12 | 50 |
In situ | 5 | 50 | 12 | 50 |
No history of NMSC (total) | 72 | 70 | ||
Invasive | 39 | 54 | 46 | 66 |
In situ | 33 | 46 | 24 | 34 |
History of melanoma (total) | 3 | 2 | ||
Invasive | 2 | 67 | 2 | 100 |
In situ | 1 | 33 | 0 | 0 |
No history of melanoma (total) | 79 | 92 | ||
Invasive | 42 | 53 | 56 | 61 |
In situ | 37 | 47 | 36 | 39 |
Abbreviations: CaD, calcium and vitamin D; NMSC, nonmelanoma skin cancer.